Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.

MLA

Cissy Kityo, et al. “Raltegravir-Intensified Initial Antiretroviral Therapy in Advanced HIV Disease in Africa: A Randomised Controlled Trial.” PLoS Medicine, vol. 15, no. 12, Dec. 2018, p. e1002706. EBSCOhost, https://doi.org/10.1371/journal.pmed.1002706.

APA

Cissy Kityo, Alexander J Szubert, Abraham Siika, Robert Heyderman, Mutsa Bwakura-Dangarembizi, Abbas Lugemwa, Shalton Mwaringa, Anna Griffiths, Immaculate Nkanya, Sheila Kabahenda, Simon Wachira, Godfrey Musoro, Chatu Rajapakse, Timothy Etyang, James Abach, Moira J Spyer, Priscilla Wavamunno, Linda Nyondo-Mipando, Ennie Chidziva, … REALITY trial team. (2018). Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial. PLoS Medicine, 15(12), e1002706. https://doi.org/10.1371/journal.pmed.1002706

Chicago

Cissy Kityo, Alexander J Szubert, Abraham Siika, Robert Heyderman, Mutsa Bwakura-Dangarembizi, Abbas Lugemwa, Shalton Mwaringa, et al. 2018. “Raltegravir-Intensified Initial Antiretroviral Therapy in Advanced HIV Disease in Africa: A Randomised Controlled Trial.” PLoS Medicine 15 (12): e1002706. doi:10.1371/journal.pmed.1002706.